dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

MRI Homepage

New study shows value of 7T MR for evaluating MS progression Can detect cortical lesions better than conventional scanners

Trice Imaging connects imaging devices of large chain healthcare provider Aleris Patients and physicians can view images on laptops, cell phones

The benefits of intraoperative MR Q&A with Dr. John Huston Mayo Clinic neuroradiologist discusses what the advanced capabilities mean for patients – as well as providers

Sound Imaging launches MR patient motion and detection system, SAMM MD Reduces repeat scans, prevents interruption to workflow

Gadolinium not required in 3T MR multiple sclerosis follow-up scans Longitude subtraction mapping just as sensitive: study

New MR methodology may distinguish benign and cancerous lymph nodes Could be used before surgery and help determine treatment

FDA gives thumbs-up to Genetesis MCG cardiac imaging system Measures magnetic fields produced by heart's electrical activity

BSWH to install Glassbeam's CLEAN blueprint to leverage machine uptime Will include integrated CMMS software by EQ2

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

Siemens focuses on digitalization at HIMSS Its expanded digital service portfolio will be on display

Researchers use zinc to identify prostate cancer under MR

by John W. Mitchell , Senior Correspondent
By relying on a zinc signature, researchers have succeeded in identifying the difference between healthy prostate tissue and cancerous tissue in mice, according to a study just published in the journal Proceedings of the National Academy of Sciences.

“Our contrast-enhanced imaging protocol may offer early detection of prostate cancer, may be able to demonstrate the total glandular burden (pervasiveness) of prostate cancer, and may offer an opportunity to judge the aggressiveness of prostate cancer,” co-author Dr. Neil Rofsky, chairman of radiology and director of translational research at UT Southwestern Medical Center, told HCB News.

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs



The researchers synthesized a molecule that binds to zinc while also containing a substance that appears as a bright signal in an MR scan. Rofsky said they were able to demonstrate that a mouse model of prostate cancer (abnormal prostate cells) shows lower zinc binding and therefore, less concentration of the accompanying brightening agent.

The result is that prostate cancer appears as a darker focus against the normally brightened gland.

"The potential for translating this method to human clinical imaging is very good, and will be useful for diagnostic purposes. The method may prove useful for monitoring therapies used to treat prostate cancer," added co-author Dr. A. Dean Sherry, Ph.D., director, Advanced Imaging Research Center and professor of chemistry.

The two colleagues became interested in the connection between zinc and cancer from a previous study of a zinc-sensitive MR contrast agent in pancreatic tissue. When they tested the technique on mouse models, they were able to successfully detect small malignant lesions as early as 11 weeks. This makes the noninvasive imaging procedure a potentially useful method for detecting the disease and its progression.

“Based on the knowledge that the highest concentration of zinc in the human body is present in the normal prostate gland, we thought it might be possible to visualize cancerous prostate tissue as a zinc deficient focus surrounded by normal concentrations of zinc in the adjacent, normal glandular tissue,” said Rofsky.

According to the American Cancer Association, one in seven men will be diagnosed with prostate cancer in their lifetime. The disease develops mainly in older men and is rare before the age of 40. Prostate cancer is the second leading cause of death of American men, behind lung cancer. There are about 26,000 deaths a year and about 181,000 new cases of prostate cancer are diagnosed every year.

The two co-authors said the next step in their study will be to research the MR and zinc connection in more complex animals.

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED